Format

Send to

Choose Destination
Nat Biotechnol. 1996 May;14(5):591-3.

Vaccine R&D success rates and development times.

Author information

1
Swiss Serum and Vaccine, Inc., Bern, Switzerland.
PMID:
9630948
DOI:
10.1038/nbt0596-591
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center